Global Cord Blood Corp
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation… Read more
Market Cap & Net Worth: Global Cord Blood Corp (CORBF)
Global Cord Blood Corp (OTCMKTS:CORBF) has a market capitalization of $154.00 Million ($154.00 Million) as of March 19, 2026. Listed on the OTCMKTS stock exchange, this USA-based company holds position #16975 globally and #6488 in its home market, demonstrating a 43.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Global Cord Blood Corp's stock price $1.15 by its total outstanding shares 133914711 (133.91 Million).
Global Cord Blood Corp Market Cap History: 2015 to 2025
Global Cord Blood Corp's market capitalization history from 2015 to 2025. Data shows change from $844.61 Million to $154.00 Million (-16.30% CAGR).
Global Cord Blood Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Global Cord Blood Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.32x
Global Cord Blood Corp's market cap is 0.32 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.80x
Global Cord Blood Corp's market cap is 0.80 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $844.61 Million | $635.12 Million | $107.29 Million | 1.33x | 7.87x |
| 2016 | $811.47 Million | $663.00 Million | $90.97 Million | 1.22x | 8.92x |
| 2017 | $1.32 Billion | $759.98 Million | $126.19 Million | 1.74x | 10.45x |
| 2018 | $863.75 Million | $936.77 Million | $237.10 Million | 0.92x | 3.64x |
| 2019 | $669.57 Million | $986.75 Million | $291.12 Million | 0.68x | 2.30x |
| 2020 | $496.82 Million | $1.22 Billion | $470.72 Million | 0.41x | 1.06x |
| 2021 | $561.10 Million | $1.16 Billion | $508.25 Million | 0.48x | 1.10x |
| 2022 | $400.40 Million | $1.24 Billion | $501.06 Million | 0.32x | 0.80x |
Competitor Companies of CORBF by Market Capitalization
Companies near Global Cord Blood Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Global Cord Blood Corp by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Global Cord Blood Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Global Cord Blood Corp's market cap moved from $844.61 Million to $ 154.00 Million, with a yearly change of -16.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $154.00 Million | -8.73% |
| 2024 | $168.73 Million | +3.28% |
| 2023 | $163.38 Million | -59.20% |
| 2022 | $400.40 Million | -28.64% |
| 2021 | $561.10 Million | +12.94% |
| 2020 | $496.82 Million | -25.80% |
| 2019 | $669.57 Million | -22.48% |
| 2018 | $863.75 Million | -34.53% |
| 2017 | $1.32 Billion | +62.58% |
| 2016 | $811.47 Million | -3.92% |
| 2015 | $844.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Global Cord Blood Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $154.00 Million USD |
| MoneyControl | $154.00 Million USD |
| MarketWatch | $154.00 Million USD |
| marketcap.company | $154.00 Million USD |
| Reuters | $154.00 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.